Combination Drug Delivery Approach as an Effective Therapy for Various Diseases

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• Section 1: Combination drug delivery approaches against various diseases1. Drug resistance as challenges to effective therapy2. Overcoming the challenges of drug resistance through combination drug delivery approach3. Combination drug delivery approaches for pulmonary diseases4. Combination drug delivery approaches in ophthalmology5. Combination drug delivery system to enhance the transdermal drug delivery6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis7. Combination drug delivery approaches for cardiovascular disease8. Combination drug delivery approaches for viral infection9. Combination drug delivery approaches for malaria parasite10. Combination drug delivery approaches for tuberculosisSection 2: Combination drug delivery approaches against cancer11. Combination drug delivery approaches for cancer therapy12. Prodrug-based drug delivery approaches in cancer combination therapy13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics14. Cocktail chemotherapy by combination drug delivery systems15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy16. Combinational chemotherapy and hyperthermia in cancer treatmentSection 3: Combination drug delivery approaches challenges and future perspectives17. Premarket review and postmarket regulation of combination drug products18. Challenges associated with nanoparticulate combination drug delivery systems19. Concluding remarks and future perspective of combination drug delivery systems